Monoclonal antibody therapy (unspecified)
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Monoclonal antibody therapy (unspecified), covering 2010-03-16 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy [EARLY_Phase 1]